MDMB-CHMINACA is an indazole-based synthetic cannabinoid that acts as a potent agonist of the CB1 receptor. MDMB-CHMINACA has been discontinued. References: Banister, Samuel D.; Longworth, Mitchell; Kevin, Richard; Sachdev, Shivani; Santiago, Marina; Stuart, Jordyn; Mack, James B. C.; Glass, Michelle; McGregor, Iain S.; Connor, Mark; Kassiou, Michael (2016). "Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues". ACS Chemical Neuroscience. 7: 1241–54. PMID 27421060. doi:10.1021/acschemneuro.6b00137.

纯度：≥98%

CAS：1185888-32-7